South Korea · Delayed Price · Currency is KRW Kolon Life Science Statistics
Total Valuation
KOSDAQ:102940 has a market cap or net worth of KRW 649.29 billion. The enterprise value is 751.07 billion.
| Market Cap | 649.29B |
| Enterprise Value | 751.07B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:102940 has 13.09 million shares outstanding. The number of shares has increased by 19.83% in one year.
| Current Share Class | 13.09M |
| Shares Outstanding | 13.09M |
| Shares Change (YoY) | +19.83% |
| Shares Change (QoQ) | +21.90% |
| Owned by Insiders (%) | 17.14% |
| Owned by Institutions (%) | 0.27% |
| Float | 7.60M |
Valuation Ratios
The trailing PE ratio is 19.86.
| PE Ratio | 19.86 |
| Forward PE | n/a |
| PS Ratio | 3.04 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 233.70 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 21.26 |
| EV / Sales | 3.51 |
| EV / EBITDA | 24.66 |
| EV / EBIT | 36.79 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 0.14.
| Current Ratio | 0.73 |
| Quick Ratio | 0.28 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 3.66 |
| Debt / FCF | -4.54 |
| Interest Coverage | 2.88 |
Financial Efficiency
Return on equity (ROE) is 6.51% and return on invested capital (ROIC) is 2.56%.
| Return on Equity (ROE) | 6.51% |
| Return on Assets (ROA) | 1.46% |
| Return on Invested Capital (ROIC) | 2.56% |
| Return on Capital Employed (ROCE) | 2.06% |
| Weighted Average Cost of Capital (WACC) | 4.68% |
| Revenue Per Employee | 503.07M |
| Profits Per Employee | 83.12M |
| Employee Count | 425 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.63 |
Taxes
In the past 12 months, KOSDAQ:102940 has paid 764.03 million in taxes.
| Income Tax | 764.03M |
| Effective Tax Rate | 2.12% |
Stock Price Statistics
The stock price has increased by +58.47% in the last 52 weeks. The beta is 0.03, so KOSDAQ:102940's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +58.47% |
| 50-Day Moving Average | 55,458.00 |
| 200-Day Moving Average | 48,173.50 |
| Relative Strength Index (RSI) | 43.51 |
| Average Volume (20 Days) | 33,663 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:102940 had revenue of KRW 213.81 billion and earned 35.33 billion in profits. Earnings per share was 2,498.04.
| Revenue | 213.81B |
| Gross Profit | 60.05B |
| Operating Income | 20.42B |
| Pretax Income | 36.09B |
| Net Income | 35.33B |
| EBITDA | 30.45B |
| EBIT | 20.42B |
| Earnings Per Share (EPS) | 2,498.04 |
Balance Sheet
The company has 9.61 billion in cash and 111.38 billion in debt, with a net cash position of -101.78 billion or -7,774.73 per share.
| Cash & Cash Equivalents | 9.61B |
| Total Debt | 111.38B |
| Net Cash | -101.78B |
| Net Cash Per Share | -7,774.73 |
| Equity (Book Value) | 784.13B |
| Book Value Per Share | 60,178.55 |
| Working Capital | -43.27B |
Cash Flow
In the last 12 months, operating cash flow was 2.78 billion and capital expenditures -27.31 billion, giving a free cash flow of -24.53 billion.
| Operating Cash Flow | 2.78B |
| Capital Expenditures | -27.31B |
| Depreciation & Amortization | 10.04B |
| Net Borrowing | -12.30B |
| Free Cash Flow | -24.53B |
| FCF Per Share | -1,874.11 |
Margins
Gross margin is 28.09%, with operating and profit margins of 9.55% and 16.52%.
| Gross Margin | 28.09% |
| Operating Margin | 9.55% |
| Pretax Margin | 16.88% |
| Profit Margin | 16.52% |
| EBITDA Margin | 14.24% |
| EBIT Margin | 9.55% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:102940 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.83% |
| Shareholder Yield | -19.83% |
| Earnings Yield | 5.44% |
| FCF Yield | -3.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KOSDAQ:102940 has an Altman Z-Score of 0.81 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.81 |
| Piotroski F-Score | 5 |